메뉴 건너뛰기




Volumn 51, Issue 55, 2004, Pages 289-293

Combined S-1 and Cisplatin Preoperative Chemotherapy for Patients with Advanced Gastric Cancer: Report of Five Cases

Author keywords

Advanced gastric cancer; Combination of S 1 and CDDP; Neoadjuvant chemotherapy

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; CISPLATIN;

EID: 10744230785     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (2)

References (25)
  • 2
    • 0000581232 scopus 로고    scopus 로고
    • State of the art in the treatment of gastric cancer: From the 71st Japanese Gastric Cancer Congress
    • Fujii M, Sasaki J, Nakajima T: State of the art in the treatment of gastric cancer: from the 71st Japanese Gastric Cancer Congress. Gastric Cancer 1999; 2:151-157.
    • (1999) Gastric Cancer , vol.2 , pp. 151-157
    • Fujii, M.1    Sasaki, J.2    Nakajima, T.3
  • 4
    • 0033231084 scopus 로고    scopus 로고
    • Adjuvant therapy for gastric carcinoma patients in the past 15 years: A review of Western and Oriental trials
    • Shimada K, Ajani JA: Adjuvant therapy for gastric carcinoma patients in the past 15 years: a review of Western and Oriental trials. Cancer 1999; 86:1657-1668.
    • (1999) Cancer , vol.86 , pp. 1657-1668
    • Shimada, K.1    Ajani, J.A.2
  • 6
    • 0020460589 scopus 로고
    • Clinical cancer research: An embattled species
    • Frei E: Clinical cancer research: An embattled species. Cancer 1982; 50:1979-1992.
    • (1982) Cancer , vol.50 , pp. 1979-1992
    • Frei, E.1
  • 7
    • 0020583556 scopus 로고
    • Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases
    • Fisher B, Gunduz N, Saffer EA: Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. Cancer Res 1983; 43:1488-1492.
    • (1983) Cancer Res , vol.43 , pp. 1488-1492
    • Fisher, B.1    Gunduz, N.2    Saffer, E.A.3
  • 11
    • 0003192645 scopus 로고    scopus 로고
    • Japanese classification of gastric carcinoma - 2nd English Edition
    • Japanese Gastric Cancer Association: Japanese classification of gastric carcinoma - 2nd English Edition. Gastric Cancer 1998; 1:10-24.
    • (1998) Gastric Cancer , vol.1 , pp. 10-24
  • 15
    • 0029044328 scopus 로고
    • Feasibility of five courses of pre-operative chemotherapy in patients with resectable adenocarcinoma of the oesophagus or gastrooesophageal junction
    • Ajani JA, Roth JA, Putnam JB, Walsh G, Lynch PM, Roubein LD, Ryan MB, Natrajan G, Gould P: Feasibility of five courses of pre-operative chemotherapy in patients with resectable adenocarcinoma of the oesophagus or gastrooesophageal junction. Eur J Cancer 1995; 31A:665-670.
    • (1995) Eur J Cancer , vol.31 A , pp. 665-670
    • Ajani, J.A.1    Roth, J.A.2    Putnam, J.B.3    Walsh, G.4    Lynch, P.M.5    Roubein, L.D.6    Ryan, M.B.7    Natrajan, G.8    Gould, P.9
  • 16
    • 0029902878 scopus 로고    scopus 로고
    • Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancer
    • Melcher AA, Mort D, Maughan TS: Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancer. Br J Cancer 1996; 74:1651-1654.
    • (1996) Br J Cancer , vol.74 , pp. 1651-1654
    • Melcher, A.A.1    Mort, D.2    Maughan, T.S.3
  • 17
    • 8944230186 scopus 로고    scopus 로고
    • Neoadjuvant therapy of high-risk gastric cancer: A phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil
    • Kelsen D, Karpeh M, Schwartz G, Gerdes H, Iightdale C, Botet J, Lauers G, Klimstra D, Huang Y, Saltz L, Quan V, Brennan M: Neoadjuvant therapy of high-risk gastric cancer: A phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil. J Clin Oncol 1996; 14:1818-1828.
    • (1996) J Clin Oncol , vol.14 , pp. 1818-1828
    • Kelsen, D.1    Karpeh, M.2    Schwartz, G.3    Gerdes, H.4    Iightdale, C.5    Botet, J.6    Lauers, G.7    Klimstra, D.8    Huang, Y.9    Saltz, L.10    Quan, V.11    Brennan, M.12
  • 19
    • 0342948592 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy with P-ELF (Cisplatin, Etoposide, Leucovorin, 5-Fluorouracil) followed by radical resection in patients with initially unresectable gastric adenocarcinoma: A phase II study
    • Gallardo-Rincon D, Onate-Ocana LF, Calderillo-Ruiz G: Neoadjuvant chemotherapy with P-ELF (Cisplatin, Etoposide, Leucovorin, 5-Fluorouracil) followed by radical resection in patients with initially unresectable gastric adenocarcinoma: a phase II study. Ann Surg Oncol 2000; 7:45-50.
    • (2000) Ann Surg Oncol , vol.7 , pp. 45-50
    • Gallardo-Rincon, D.1    Onate-Ocana, L.F.2    Calderillo-Ruiz, G.3
  • 20
    • 0026560221 scopus 로고
    • Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: Results of a phase II trial
    • Lerner A, Gonin R, Steele GD Jr: Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: results of a phase II trial. J Clin Oncol 1992; 10:536-540.
    • (1992) J Clin Oncol , vol.10 , pp. 536-540
    • Lerner, A.1    Gonin, R.2    Steele Jr., G.D.3
  • 21
    • 9344248389 scopus 로고    scopus 로고
    • Antitumor activity of 1 M tegaful-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats
    • Shirasaka T, Nakano K, Takechi T, Satake H, Uchida J, Fukushima M: Antitumor activity of 1 M tegaful-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats. Cancer Res 1996; 56:2602-2606.
    • (1996) Cancer Res , vol.56 , pp. 2602-2606
    • Shirasaka, T.1    Nakano, K.2    Takechi, T.3    Satake, H.4    Uchida, J.5    Fukushima, M.6
  • 22
    • 0032819756 scopus 로고    scopus 로고
    • An early phase II study of oral S-1, a newly developed 5-fluorouracil derivative for advanced and recurrent gastrointestinal cancers
    • Sugimachi K, Maehara Y, Horikoshi N, Shimada Y, Sakata Y, Mitachi Y: An early phase II study of oral S-1, a newly developed 5-fluorouracil derivative for advanced and recurrent gastrointestinal cancers. Oncology 1999; 57:202-210.
    • (1999) Oncology , vol.57 , pp. 202-210
    • Sugimachi, K.1    Maehara, Y.2    Horikoshi, N.3    Shimada, Y.4    Sakata, Y.5    Mitachi, Y.6
  • 23
    • 0032189218 scopus 로고    scopus 로고
    • Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegaful-0.4M gimestat-1M otastat potassium) in advanced gastric cancer patients
    • SakataY, Ohtsu A, Horikoshi N, Sugimachi K, Mitachi Y, Taguchi T: Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegaful-0.4M gimestat-1M otastat potassium) in advanced gastric cancer patients. Eur J Cancer 1998; 34:1715-1720.
    • (1998) Eur J Cancer , vol.34 , pp. 1715-1720
    • Sakata, Y.1    Ohtsu, A.2    Horikoshi, N.3    Sugimachi, K.4    Mitachi, Y.5    Taguchi, T.6
  • 25
    • 0033498239 scopus 로고    scopus 로고
    • Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer
    • Lowy AM, Mansfield PF, Leach SD, Pazdur R, Dumas P, Ajani JA: Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer. Ann Surg 1999; 229:303-308.
    • (1999) Ann Surg , vol.229 , pp. 303-308
    • Lowy, A.M.1    Mansfield, P.F.2    Leach, S.D.3    Pazdur, R.4    Dumas, P.5    Ajani, J.A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.